Page last updated: 2024-10-16

betaine and Bone Diseases

betaine has been researched along with Bone Diseases in 1 studies

glycine betaine : The amino acid betaine derived from glycine.

Bone Diseases: Diseases of BONES.

Research Excerpts

ExcerptRelevanceReference
"To validate our hypothesis that a bisphosphonate (BP) having a nitrogen-containing heterocyclic ring on the side chain, and with no hydroxyl on the geminal carbon would possess increased activity, and better oral bioavailability due to enhanced solubility of its calcium complexes/salts and weaker Ca chelating properties."1.30Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate. ( Alferiev, IS; Breuer, E; Cohen, H; Ezra, A; Golomb, G; Hägele, G; Hoffman, A; Mönkkönen, J; Ornoy, A; Patlas, N; Pinto, T; Sagi, H; Seibel, MJ; Solomon, V; Stepensky, D, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, H1
Alferiev, IS1
Mönkkönen, J1
Seibel, MJ1
Pinto, T1
Ezra, A1
Solomon, V1
Stepensky, D1
Sagi, H1
Ornoy, A1
Patlas, N1
Hägele, G1
Hoffman, A1
Breuer, E1
Golomb, G1

Other Studies

1 other study available for betaine and Bone Diseases

ArticleYear
Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.
    Pharmaceutical research, 1999, Volume: 16, Issue:9

    Topics: Administration, Oral; Alendronate; Animals; Antineoplastic Agents; Betaine; Bone Diseases; Bone Neop

1999